info@seagull-health.com
SeagullHealth
语言:
search

How should I use Truqap(Capivasertib)?

Guidelines on how to use and dose the medication.

Dosage and Administration

The recommended dosage is 400 mg taken orally twice daily (approximately 12 hours apart), with or without food. This dosing follows an intermittent schedule: four consecutive days on treatment followed by three days off each week. Treatment continues until disease progression or unacceptable toxicity. Dose modifications, including interruptions, reductions, or discontinuation, are required for managing specific adverse reactions and for concomitant use with certain CYP3A inhibitors.

Capivasertib(Truqap)
Capivasertib(Truqap)
Used in combination with fulvestrant for the treatment of HR-positive,...
WeChat Scan
Free Inquiry
Related articles
Dosage and Administration of Capivasertib
Capivasertib is a novel kinase inhibitor that received its first approval in the United States in 2023. As a precision therapy targeting specific gene mutations, it has demonstrated favorable efficacy...
How to Use Capivasertib
Capivasertib is an AKT kinase inhibitor that was approved for marketing in the United States in 2023. It is indicated for the treatment of locally advanced or metastatic breast cancer that is hormone ...
How to Use Capivasertib
Capivasertib is an AKT kinase inhibitor that was approved for marketing in the United States in 2023. It is indicated for the treatment of locally advanced or metastatic breast cancer that is hormone ...
Instructions for use and indications of Indian Capivasertib
Capivasertib(Truqap) is a targeted therapy for patients with specific breast lesions and should be used strictly in accordance with the doctor's instructions. Correct use of the drug can impr...
共 4 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved